Avalo Therapeutics, Inc. (AVTX)
16.12
-1.06
(-6.17%)
USD |
NASDAQ |
Sep 11, 16:00
16.11
-0.01
(-0.06%)
After-Hours: 20:00
Avalo Therapeutics Price : 16.12 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 17.42 | 18.14 | 16.02 | 16.12 | 2.525M |
| Sep 10, 2026 | 17.92 | 18.05 | 17.15 | 17.18 | 913754.0 |
| Sep 09, 2026 | 19.47 | 19.74 | 18.04 | 18.21 | 725724.0 |
| Sep 08, 2026 | 19.01 | 20.49 | 18.95 | 19.71 | 779695.0 |
| Sep 04, 2026 | 18.81 | 19.62 | 18.79 | 19.23 | 633231.0 |
| Sep 03, 2026 | 19.57 | 19.57 | 18.73 | 19.00 | 674036.0 |
| Sep 02, 2026 | 19.00 | 19.86 | 19.00 | 19.34 | 988015.0 |
| Sep 01, 2026 | 19.19 | 19.70 | 18.85 | 18.95 | 606643.0 |
| Aug 31, 2026 | 19.40 | 19.58 | 19.00 | 19.34 | 1.377M |
| Aug 28, 2026 | 19.87 | 20.18 | 19.54 | 19.59 | 738276.0 |
| Aug 27, 2026 | 20.47 | 20.57 | 19.91 | 20.05 | 420540.0 |
| Aug 26, 2026 | 19.74 | 20.94 | 19.61 | 20.55 | 813986.0 |
| Aug 25, 2026 | 19.54 | 20.05 | 19.36 | 19.74 | 1.015M |
| Aug 24, 2026 | 19.86 | 19.86 | 18.88 | 19.27 | 759039.0 |
| Aug 21, 2026 | 20.02 | 20.19 | 19.58 | 19.83 | 569830.0 |
| Aug 20, 2026 | 20.38 | 20.59 | 19.49 | 19.82 | 698456.0 |
| Aug 19, 2026 | 20.41 | 21.02 | 20.14 | 20.75 | 999046.0 |
| Aug 18, 2026 | 19.91 | 20.46 | 19.62 | 19.71 | 1.069M |
| Aug 17, 2026 | 19.48 | 20.07 | 19.32 | 19.95 | 646969.0 |
| Aug 14, 2026 | 19.13 | 19.63 | 18.34 | 19.59 | 388067.0 |
| Aug 13, 2026 | 19.65 | 19.67 | 19.19 | 19.45 | 391152.0 |
| Aug 12, 2026 | 19.52 | 19.77 | 19.27 | 19.55 | 317250.0 |
| Aug 11, 2026 | 19.67 | 20.00 | 18.86 | 19.47 | 714965.0 |
| Aug 10, 2026 | 18.25 | 20.00 | 18.00 | 19.77 | 977860.0 |
| Aug 07, 2026 | 18.87 | 19.05 | 17.90 | 18.32 | 730255.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.83 |
| Incyte Corp. | 121.47 |
| AbbVie, Inc. | 257.12 |
| Rezolute, Inc. | 4.22 |
| Alnylam Pharmaceuticals, Inc. | 248.68 |
Price Related Metrics
| PS Ratio | 6572.47 |
| Price to Book Value | 1.901 |
| Earnings Yield | -29.40% |
| Market Cap | 852.76M |